SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
Shaye
Lv1
90 积分
2023-12-04 加入
最近求助
最近应助
互助留言
Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate Cancer
8天前
已完结
Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer
9天前
已完结
Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer
9天前
已完结
Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer
1个月前
已完结
Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial
1个月前
已完结
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
1个月前
已完结
Daratumumab in first-line is cost-effective in transplant-eligible newly diagnosed myeloma patients
1个月前
已完结
Navigating the evolving therapeutic landscape in advanced prostate cancer
1个月前
已完结
A Novel Therapeutic Option for Castration-resistant Prostate Cancer: After or Before Chemotherapy?
1个月前
已完结
[Expert consensus on homologous recombination repair gene testing and variant interpretation in prostate cancer]
1个月前
已完结
没有进行任何应助
标题错误、doi错误
9天前
这个好像不是我求助的文献哦~
9天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论